Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
Alessia Costa, Minrong Ai, Nicolas Nunn, et al.
Molecular Metabolism (2021) Vol. 55, pp. 101407-101407
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff, et al.
The Lancet (2023) Vol. 402, Iss. 10402, pp. 613-626
Open Access | Times Cited: 317
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
Michael A. Nauck, David A. D‘Alessio
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 175
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Vicky Chuong, Mehdi Farokhnia, Sophia Khom, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 81
Dissociable hindbrain GLP1R circuits for satiety and aversion
Kuei-Pin Huang, Alisha A Acosta, Misgana Y. Ghidewon, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 585-593
Closed Access | Times Cited: 30
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Glucose-dependent insulinotropic polypeptide (GIP)
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 2
GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
Ricardo J. Samms, Richard Cosgrove, Brandy M. Snider, et al.
Diabetes (2022) Vol. 71, Iss. 7, pp. 1410-1423
Open Access | Times Cited: 41
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Yuan Zeng, Yifan Wu, Qian Zhang, et al.
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
Alice E. Adriaenssens, Johannes Broichhagen, Anne de Bray, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 28
Stimulating intestinal GIP release reduces food intake and body weight in mice
Jo E. Lewis, Danaé Nuzzaci, Paula-Peace James-Okoro, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101945-101945
Open Access | Times Cited: 8
A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy
Filip K. Knop, Shweta Urva, Mallikarjuna Rettiganti, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 5474-5478
Open Access | Times Cited: 8
GLP-1 receptor agonist as a modulator of innate immunity
Jun Chen, Aihua Mei, Yingying Wei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Dual gut hormone receptor agonists for diabetes and obesity
Joseph Bass, Matthias H. Tschöp, Lisa R. Beutler
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 18
GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
Ziqi Zhang, Qiling Zhang, Ying Tan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
Glucagon-Like Peptide 1 Receptor Agonists in Psychiatry
Hubertus Himmerich, Susan L. McElroy
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 6
Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms
Bruno Vergès, Victor Aboyans, Denis Angoulvant, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Aaron Novikoff, Timo D. Müller
Physiology (2024) Vol. 39, Iss. 3, pp. 142-156
Closed Access | Times Cited: 5
Neuroendocrine gut–brain signaling in obesity
Tim Gruber, Franziska Lechner, Jean‐Philippe Krieger, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 5
A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
Yikuan Du, Mengting Zhang, Zhenjie Wang, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 10, pp. 1422-1433
Open Access | Times Cited: 5
Neural pathways of nausea and roles in energy balance
Chuchu Zhang
Current Opinion in Neurobiology (2025) Vol. 90, pp. 102963-102963
Open Access
Cholecystokinin (CCK) Is a Mediator Between Nutritional Intake and Gonadal Development in Teleosts
Hangyu Li, Hongwei Liang, Xiaowen Gao, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 78-78
Open Access
GLP-1RA: New Hope in Obesity Therapy
Danfeng Zhang, Hongyun Lu
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 02, pp. 465-479
Open Access
The role of GIPR in food intake control
Paula-Peace James-Okoro, Jo E. Lewis, Fiona M. Gribble, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Islet effects of cholecystokinin and exploitation in diabetes
Neil Tanday, Nigel Irwin, Peter R. Flatt
Elsevier eBooks (2025), pp. 305-325
Closed Access
Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo‐controlled clinical trials
Yu Mi Kang, Viktoria Punov, Soo Lim, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Page 1 - Next Page

Scroll to top